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Pra PTCA TIMI HOW Pre PTCA CTFC Post PTCA CTFC Delta CTFC
TIMI 0/1 Occluded 28.5 + 16.5, n = 70 Nonapplicable
TIMI 2 63.2 + 37.0, n = 25 26.3+ 17.8, n = 19 43.7+42.6, n = 19
TtMl 3 30.6 + 9.9, n = 19” 20.5+ 11.5, n =16 10.3* 12.8, n = 16
TtMl 2 or3 49.1 & 32.6, n = 44 23.5& 15.1, n =37 27.4 k 35.6, n =37
Previously we reported that normalarteriesin the absence of acute Ml
have a CTFC of 21.0 + 3.1 (n = 78). PTCA of arteries with TIMI 3 Flow
reatored a normal CTFC (20.5 vs 21.0, p = NS). Adjunctive PTCA of arteries
with TIMI 2 flow improved flow by 43.7 frames (p = 0.0006) but did not restore
a normal CTFC (26.3 vs 21.0 p = 0.01) and approximates that repotted for
non-culprit arteries in acute Ml (25.5 frames). Likewise, rescue PTCAof TIMI
0/1 flow did not restore a normal CTFC (28.5 vs 21.0, p = 0.0001). Slower
Pra PTCA CTFCS were correlated with greeter improvements in CTFC (r =
0.91, p -=0.0001). Conclusions: PTCAof the residual stenosis in arteries with
TIMI 3 flow atter thromboiysis results in normal flow (CTFC = 21). Although
PTCA of the reeidual stenosis in arteries with TIMI 2 flow greatly improves
flow, the flow remains peraietently slowed by 5 frames (20% > normal). This
5 frame delay is similar to that observed in non-culprit arteries in acute Ml,
& may reflect a peraietent abnormality in microvascular reeistence.Whether
PTCA of atteries with TIMI 2 flow improves clinical outcomea remains to be
determined. -
m94620 Clinical Usefulness of Dual SPECT Imaging ofTc.ggm ~stamibi and 1231-IPPA for Predicting
Myocardial Viability After Thrombolyaed
Myocardial Infarction
M. Pence, S. Romano, S. Rosanio, M. Tocchi, A. Vitarelli, A. Dagianti,
M. Benci, F. Scopinero 1,F. Fedele, A. Dagianti. Dpt. of Cardiovascular and
Respiretory Sciences, “Le Sepienza” University Rome, /ta@,1Dpt. of
Experimental Medicine, “La Sapienza” Unive~ity Rome, Itafy
There ie controversy on the value of Tc-99m Sestamibi SPECT (MIBI) for
detection of myocerdial viability. This study”wae performed to investigate
the ability of MIBI in conjunction with 1231-Phenylpentadaoenoicacid (IPPA)
in identifying dysfunctional but viable myocardium after earty (<4 hours)
thromlmlytic treatment for myocerdial infarction (Ml). We compared, in mr-
responding myocerdial segments, perfusion and metabolic patterns in 22
petienta with firat uncomplicated Ml (16 males, age 36t064 yra) after4 * 1.5
daya from symptoms oneet. Myocardial viability wea defined by the discrep-
ancy bStWSenparfueion defect on MIBI and fatty acid metabolism on IPPA
SPECT:dual SPECTimage aequieition in 3 projactione (anterior,45Qand 71Y
tAO) wea carried out at 60 min from MIBI and 30 min from IPPA injections.
The Ieftventricle weadivided into 9 eagmente (apex, 4distel and4besal seg-
mente) and analyzed using a quantitative uptake score as normal = 1, mild
reduction =2, eevere reduction= 3, defect =4. Toassessfunctional recovery
of eaynergic areas, all patients underwent 2D achocardiography evaluating
wall motion score index (WMSI) and ejeetion fraction (EF) on the same day
of radionuclide imaging and 8 weeke after: improvement was defined as
decrease of WMSI ? 1. WMSI at baeeline well correlated with IPPA score (r
= o.i’6, p < 0.01) while did not with MIBI score (r= o.61, P = ne). The lppA
score wae significantly larger than the MIBI score (6.7 +3.1 vs 3.4+2.1, p <
0.01) The discrepancy between IPPA and MIBI was significantly correlated
with the extent of the improvement of WMSI (r= 0.66, p < 0.01) and of EF (r =
0.60, p c 0.01) at 6 weeks. In conclusion, the identification by dual MIBI and
IPPA SPECT of segmental metabolism-perfusion mismatch (possibly due
to stunning phenomenon after thrombolysad myooerdial infarction) predicts
myoeardial viability and later recovery.of left ventricular contractile function.
D94621 Pereietent Myoglobin Elevetion ia Associated withSlower Flow in Patent Culprit Afteries Following
Successful Thrombolysis
M. Rizzo, 1.Doteni, C. McLean, K. Ryan, C. McCabe, M. Tanasijevic,
C. Cannon, M. Gibson, E. Braunwald, for the TIMI IOA Trialists. Wast
Roxbwy VAMedical Center and Brfgham & Women’s Hospital, Boston, MA,
USA
This study examined the relationship between the release of myoglobin and
blood flow in patent culprit atieries at 90min. following thrombolyais with TNK
in TIMI loA. The frames required for dye to reach standard landmarks were
counted to arrive at the Corrected TIMI Frame Count (CTFC), a previously
described index of coronary blood flow. Slower 90 min. flow (i.e. higher
CTFCS)was correlated with higher12 hour(r= 0.66, p = 0.13331,n = 34), &
higher24 hourmyoglobinlevels(r= 0.65, p = 0.0001, n = 35) (24 hourdata
showninfigure)andtendedto behigherat 6 houra(r= 0.32, p =0.056). The
24 hr. mean myoglobin of pta. with slow flow (CTFC z 40) (116.5 + 65.5, n
=9) did not differ from that of pts. with a closed artety (137.8 & 156.9, n = 5,
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P= NS)butwashigherthanpta.withmore rapid90 min.flow (CTFC c 40)
(55.5 + 4.7, n = 26, p = 0.001).
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Conclusions: Slower flow in patent culprit arteries at 90 min. folIowing
thrombolysis is associated with a persistent elevation of myoglobin at 12 and
24 hra which approximates that observed in occluded arteriee, possibly as a
result of delayed washout.
1946-22]D*aTIMIFramecountRefledMYo.ardialBled
Flow?
A. Huizenga, W.R.M. Aengevaeren, T. van der Werf, F.W.A.Verheugt.
Depetiment of Cardiology, University Hospital Nijmegen, The Netherlands
TIMI frame count (TFC), presented as a simple, reproducible quantitative
index of coronary blood flow, is the numbarof frames needed for the appear-
ance of the front of the contrast bolus !O reach predefine distal landmarks.
From the indicetordilution thaory follows, however, that appearance time has
only a weak relation with flow. Mean transit time (MTT), on the other hand,
ie fundamentally related to myooardial flow. The MTT-method has been suc-
cessfully teeted against direct flow measurements in dogs. Therefore, we
coneiderad a comparison between the simply applicable TFC and laborious
MTT ueeful.
We atudisd 109 coronary arteriograms of atable patienta, previously in-
cluded into cholesterol lowering trials, from whom the MU’S were alrasdy
aseessed. TFC was determined by 2 independent angiogrephera, blinded
to the MTT date. If this reaulted in a difference of >5 framee, oonsensue
was reached with a third obaewer. MU, from injection site to a myocar-
dial area of interest, was assessed by digital subtraction angiography with
videodensitometric analyses of the time couffie of the contrast.
Linear regression analysis between TFC (frames) and MU (see) on all
arterial and on LAD, LCX and RCA territories separately showed correlation
coefficients of 0.12, 0.20, 0.26 and 0.31, respectively. These poor reeultadid
not change substantially by excluding thoee observations, in which there was
a difference of >5 frames between observera (about 20% of all oases).
Conclusion: Ae expected, TFC does not seem to reflect myocerdial flow,
as measured by MU, instable coronary patients. TFC, therefore, is probably
of limited value in the quantitation of myocerdial blood flow restoration in
acute myocardial infarction.
1946-231Translumina,EfiraCtiOnAthereCtomy.va.Balloon
angioplasty in Acute Ischemic Syndromes (TOPIT):
Hospital outcome and six-month status
T.L. Schreiber, B.M. Kaplan, M.L. Gregory, C.L. Brown, Ill, D.G. Rizik,
R.R. Masden, A. Brahimi, W.W. O’Neill. William Beaumont Hospital, Royal
Oak, Ml, USA, St. John Hospital, Detroit, Ml, USA
The TOPIT Trial is a randomized, multicanter study comparing the use
of tmnsluminal extraction atherectomy (TEC) veraus balloon angioplaaly
(PTCA) in native veesels for clinical situation which are associated with in-
traooronaty thrombue. We hypothesize that pretreatment with TECenhances
outcome during percutaneous revascularization for high rick patiente with
acute ischemic ayndromes. 115patients (mean age 60.Ojwere randomized
to TEC while 135 patients (mean age 56.7 year) to PTCA. Clinical indioe-
tiona included pnmaty reperfusion for acute myocardial infarction (31.6f%),
unatable angina (30.8%), post-infarction angina (24.8%), and thromboifiic
failure (10%),
Outcomes were:
TEC 115 PTCA 135 0 value
Death in hospital 1 (0.67”A) o NS
EmergentCABG 1 (0.s7%) 1 (0.s7%) NS
Emergent PTCA 5 (4,35%) 5 (3.70”/0) NS
Initial% stenosis 75.2 + 16.7 76.6 & 17.5 NS
Final ‘A stenoais 26.2 & 1S,4 27.6 + 16.9 NS
Final% thrombosis 6“/0 3% NS
3x increase CPK 1.6.3% 5.69% o.oa2
